Edition:
United States

People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

78.34USD
25 May 2017
Change (% chg)

$0.38 (+0.49%)
Prev Close
$77.96
Open
$77.92
Day's High
$78.45
Day's Low
$77.77
Volume
458,719
Avg. Vol
1,091,345
52-wk High
$86.71
52-wk Low
$64.25

Kaelin, William 

Dr. William G. Kaelin Jr., M.D., is Independent Director of the Company. He is a prominent medical researcher and academician. He has extensive experience at Harvard Medical School, a major medical institution, as well as special expertise in oncology—a key component of Lilly's business. He also has deep expertise in basic science, including mechanisms of drug action, and experience with pharmaceutical discovery research.

Basic Compensation

Total Annual Compensation, USD 134,000
Restricted Stock Awards, USD 160,000
Long-Term Incentive Plans, USD --
All Other, USD 20,500
Fiscal Year Total, USD 314,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Lechleiter

18,367,100

David Ricks

--

Derica Rice

7,920,630

Jan Lundberg

6,474,900

Melissa Barnes

--

Michael Harrington

5,393,440
As Of  30 Dec 2016